Knight Therapeutics Files Annual Information Form

MONTREAL, April 09, 2020 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, has filed its Annual Information Form for the year ended December 31, 2019 today.
Knight had previously announced that as a result of the COVID-19 impact, it was relying on the temporary relief afforded by DÉCISION N°2020-PDG-0023 of the Autorités des Marchés Financiers in respect of the obligation to file its Annual Information Form under National Instrument 51-102, Section 6.2.  The Company has now filed its Annual Information Form which may be found under its profile on Knight Therapeutics Inc.
Resource News, Oil and Gas News, Mining News, Renewable News

Resource News

Oil, Gas, Mining & Metals

Start typing and press Enter to search